检索：
选择专题分论坛：
- 不限
- 乙肝治愈转化医学研究 Translational study for functional cure of chronic HBV infection
- 肝癌及门脉高压治疗 Treatment of liver cancer and portal hypertension
- 肝衰竭、人工肝、重症感染 Liver failure, artificial liver, severe infection
- 肿瘤免疫治疗及转化研究 Tumor Immunotherapy and Translational Research
- 精准医学高峰论坛 Precision Medicine Summit Forum
- 国际消除病毒性肝炎论坛 International Forum on Elimination of Viral Hepatitis
- 新药研发热点 New drug research and development hotspots
- 中法肝病论坛：肝病无创诊断技术最新进展及应用 Sino-French Liver Diseases Forum：Advancement & Application of Non-invasive Diagnostic Technology
- 传染病国家级平台学科建设高峰论坛 National Platform for Discipline Construction of Infectious Diseases Summit Forum
- 介入专场 Intervention Session
- 医防融合：社区和MDT管理培训 Medical and prevention integration: community and MDT management training
选择日期：
- 不限
- 2021-12-10 [星期五]
- 2021-12-11 [星期六]
- 2021-12-12 [星期日]
选择会场：
- 不限
- 主会场（大沙龙厅） The Main Venue（Dashalong Hall）
- 大沙龙厅1 Dashalong Hall 1
- 大沙龙厅2 Dashalong Hall 2
- 大沙龙厅3 Dashalong Hall 3
2021-12-10 星期五
大沙龙厅1 Dashalong Hall 1
14:30-15:50
| 肝癌及门脉高压治疗-Session 1 Treatment of liver cancer and portal hypertension-Session one 【肝癌及门脉高压治疗 Treatment of liver cancer and portal hypertension】
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 14:30-14:50 |
肝癌的免疫治疗 |
Richard S. Finn | Department of Surgery, Dumont-UCLA Liver Cancer Center |
|
Incorporating Immunotherapy into the Management of HCC |
Richard S. Finn | Department of Surgery, Dumont-UCLA Liver Cancer Center | |
| 14:50-15:10 |
实验介入学VS前沿介入技术 |
李茂全 | 同济大学附属第十人民医院 |
|
Experimental Intervention vs Frontier Intervention Technology |
Maoquan Li | Tenth People's Hospital of Tongji University | |
| 15:10-15:30 |
ACTA的研究进展及他汀类药物的临床实践带给我们的启示 |
江家骥 | 福建医科大学附属第一医院 |
|
Research progress of ACTA and the inspiration from clinical practice of statins |
Jiaji Jiang | The First Affiliated Hospital of Fujian Medical University | |
| 15:30-15:50 |
中国原发性肝癌诊疗规范 |
任正刚 | 复旦大学附属中山医院 |
|
Standards for diagnosis and treatment of primary liver cancer in China |
Zhenggang Ren | Zhongshan Hospital Red Cross Hospital |
15:50-16:10
| 茶歇 Coffee break 【肝癌及门脉高压治疗 Treatment of liver cancer and portal hypertension】
16:10-17:30
| 肝癌及门脉高压治疗-Session 2 Treatment of liver cancer and portal hypertension-Session two 【肝癌及门脉高压治疗 Treatment of liver cancer and portal hypertension】
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 16:10-16:30 |
门静脉癌栓诊疗 |
程树群 | 海军军医大学第三附属医院（东方肝胆外科医院） |
|
Portal vein cancer thrombus diagnosis and treatment |
Shuqun Cheng | Eastern Hepatobiliary Surgery Hospital | |
| 16:30-16:50 |
肝癌放疗 |
曾昭冲 | 复旦大学附属中山医院 |
|
Radiotherapy for liver cancer |
Zhaochong Zeng | Zhongshan Hospital Red Cross Hospital | |
| 16:50-17:10 |
肝癌根治术 |
匡铭 | 中山大学附属第一医院 |
|
Radical resection of liver cancer |
Ming Kuang | The First Affiliated Hospital, Sun Yat-Sen University, China | |
| 17:10-17:30 |
肝癌治疗分子标志物进展 |
刘莉 | 南方医科大学南方医院 |
|
Progress of molecular markers in the treatment of liver cancer |
Li Liu | Nanfang Hospital, Southern Medical University |
17:30-17:50
| 肝癌及门脉高压治疗-Session 3 Treatment of liver cancer and portal hypertension-Session three 【肝癌及门脉高压治疗 Treatment of liver cancer and portal hypertension】
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 17:30-17:50 |
专题研讨会：卡瑞利珠单抗-肝癌免疫治疗新进展 |
陈锦章 | 南方医科大学南方医院 |
|
Symposium: Carrelizumab-New Progress in Immunotherapy of Liver Cancer |
Jinzhang Chen | Nanfang Hospital, Southern Medical University |
美迪康会务通